Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
about
Approach to Cutaneous Lymphoid Infiltrates: When to Consider Lymphoma?Primary cutaneous lymphomas: diagnosis and treatmentDifferential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomasNodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases.Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.Phenotypic characterization of subsets of T cell lymphoma: towards a functional classification of T cell lymphoma.Primary cutaneous T-cell lymphomas: a review.The World Health Organization classification of malignant lymphoma: incidence and clinical prognosis in HTLV-1-endemic area of Fukuoka.Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphoma.The new World Health Organization classification of haematopoietic and lymphoid tumours: a dermatopathological perspective.The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: an immunohistochemical study of tissue microarrays.Two cases of lymphomatoid papulosis in children.A case of poikiloderma vasculare atrophicansCharacteristics of cutaneous lymphomas in Korea.Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: a systematic analysis of 156 patients reported in the literature.The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects.Classification of cutaneous T-cell lymphoma: from Alibert to WHO-EORTC.Classification and treatment of rare and aggressive types of peripheral T-cell/natural killer-cell lymphomas of the skin.Need for an improved molecular/genetic classification for CD30+ lymphomas involving the skin.CD8+ cutaneous T-cell lymphoma successfully treated with bexarotene: a case report and review of the literature.CD8-positive mycosis fungoides and primary cutaneous aggressive epidermotropic CD8-positive cytotoxic T-cell lymphoma.Epidermotropic lesions: a review.Classification of cutaneous lymphomas - an update.Immunocytochemistry and the diagnosis of cutaneous lymphoma.Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management.Guidelines for the management of cutaneous lymphomas (2011): a consensus statement by the Japanese Skin Cancer Society - Lymphoma Study Group.Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop.γδ T-cell-rich variants of pityriasis lichenoides and lymphomatoid papulosis: benign cutaneous disorders to be distinguished from aggressive cutaneous γδ T-cell lymphomas.Childhood mycosis fungoides with a CD8+ CD56+ cytotoxic immunophenotype.Peripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications.Expression of cutaneous lymphocyte-associated antigen and TIA-1 by lymphocytes in pityriasis lichenoides et varioliformis acuta and lymphomatoid papulosis: immunohistochemical study.Paediatric cutaneous lymphomas: a review and comparison with adult counterparts.CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas.Primary Cutaneous CD8(+) CD30(+) Anaplastic Large Cell Lymphoma: An Unusual Case with a High Ki-67 index-A Short Review.Clinical manifestations and pathogenesis of cutaneous lymphomas: current status and future directions.Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.Hematopoietic stem cell transplantation in advanced cutaneous T-cell lymphoma.Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with KIR3DL2 and NKp46 expression in a human immunodeficiency virus carrier.Aggressive CD8(+) epidermotropic cutaneous T-cell lymphoma associated with homozygous mutation in SAMHD1.
P2860
Q26741951-33C4AB8F-1C78-4519-8335-32AADD794C47Q26772207-35E9487B-9991-4001-BE4B-C6F61445F9C1Q28364322-3B66F73A-4B35-4BA4-B670-9866EE645100Q33401775-7799513B-E6B4-4680-A506-2A26516D424AQ33929834-15ADCB86-CECD-46B0-A866-93415501ABA5Q34293431-A1F3ABDF-0D65-4C77-83E8-0C1E5E1489E1Q34502896-1D9071FC-9273-4ED8-9AE1-E583F6F7E8FEQ34592391-D2CB6860-D4C1-415F-9A24-27FA18B05CABQ34808244-8A9B18A4-CC6E-4EA8-88A5-B4981AC91C23Q34941236-216D4671-F443-424A-B86F-A4BE2AA0AD50Q34996501-A7971912-36EC-4C55-B1D1-3EF4C671E67BQ35092105-89497118-6584-4279-9915-65EC953C8ADFQ35422748-677AA8BF-6836-489E-88BA-3FA62628C530Q35583375-F6A05D3C-BDF6-4E61-89CB-36CEBCB49E8CQ35887898-9E460003-A673-496E-A38D-2E25277E884DQ36286422-081AF0CA-4415-4616-9420-0EA48A4E6564Q36315227-B250173F-9B49-4C97-8538-9E0F5E819411Q36367910-ED0AFB83-535F-40EB-BE9A-8FF228EEC4E2Q36771221-8706BC17-1354-43C9-A6AF-DCD7EBA006AEQ36771224-4C3A31C7-E982-46F3-A38E-10F4B5F0326BQ37211965-F2304197-BC13-45D7-A99B-C896ECCFB1BBQ37394347-C253118D-1791-4E05-BB9D-7C8596DCD0DCQ37564644-815CFA7F-1AE9-433F-A37C-5E9671529820Q37670303-9342F141-EFAB-47A6-92CE-E910FB1714F1Q37670306-982DC2C8-D2F1-406F-97D2-736C034C1A47Q37944565-D93E7CFD-C328-4152-A207-9080406035E8Q38035410-A191226B-318B-46D9-9649-ED0515F06FC6Q38179483-E9515E55-29F4-4F05-96ED-DB1EB290D9A3Q38241799-6B8C5E04-48C5-4482-8A50-8D4F7715B844Q38274251-4C725242-A57E-40F5-85D7-AC1C061CD56BQ38289038-0290A8CA-ACF7-4281-B525-04736728032AQ38297090-6AF88749-92B6-45E0-A735-9FEFF9D65039Q38365226-01467A7A-ADB2-4615-9890-DAACF778DC83Q38388719-FEA6295B-B154-4294-9A12-D0E62A13465AQ38569508-7567BCC5-C9F9-4AA5-8BBB-20AFB817F0F2Q38805440-E44E4DA8-556B-44C5-AE44-600E09B7B14DQ38813983-3C2DD8EB-D1C7-4F76-8F87-336FA1B5C547Q38845879-129F9EDA-5A88-4A71-B47E-64DCA5F77093Q39096442-5E60ABB6-2927-4103-9F6D-3B7816074D35Q39535114-C3C025DE-1B60-43AA-9461-1339DB413017
P2860
Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Primary cutaneous CD8-positive ...... aggressive clinical behavior.
@ast
Primary cutaneous CD8-positive ...... aggressive clinical behavior.
@en
type
label
Primary cutaneous CD8-positive ...... aggressive clinical behavior.
@ast
Primary cutaneous CD8-positive ...... aggressive clinical behavior.
@en
prefLabel
Primary cutaneous CD8-positive ...... aggressive clinical behavior.
@ast
Primary cutaneous CD8-positive ...... aggressive clinical behavior.
@en
P2093
P2860
P1476
Primary cutaneous CD8-positive ...... aggressive clinical behavior.
@en
P2093
C J Meijer
D Tomasini
M H Vermeer
R Willemze
P2860
P304
P356
10.1016/S0002-9440(10)65144-9
P407
P50
P577
1999-08-01T00:00:00Z